Donated Drug Reporting Templates to Support Neglected Tropical Disease (NTD) Program Implementation WHO SMART Guidelines approach
Donated Drug Reporting Templates to Support Neglected Tropical Disease (NTD) Program
John Snow, Inc.[link] and Standard Co [link], with financial support from the Bill & Melinda Gates Foundation [link], conducted an assessment of the tools and processes used to manage, direct, use, report, and store last mile tools and processes used to manage donated medicines used for Neglected Tropical Disease (NTD) control and elimination programmes for the five PC-NTDs.
While this project focused on evaluating the people, systems, and processes used to track last mile supply chain for Mass Drug Administration (MDA) donated medicines in eight priority countries (DRC, Ethiopia, Kenya, Madagascar, Mozambique, Nigeria, Tanzania, and Uganda), the recommendation templates are applicable for reporting inventory of MDA donated medicines in any country with considerations for unique country context.
The target population for this tool is national NTD Program Managers, implementing NGO partners, and project sponsors. The timely reporting of data on donated medicines received, used, wasted, expired, and remaining, helps to ensure that the production and distribution of new medicines are delivered to sites around the world for distribution to endemic communities in the appropriate quantities.
In 2022, the World Health Organization (WHO) published the “Standard Operating Procedures for Supply Chain Management of Health Products for Neglected Tropical Diseases Amenable to Preventive Chemotherapy.” [link] This document provides detailed procedures covering various aspects of supply chain management, including:
The mechanism for reporting medicines is through the Joint Application Package (JAP) [link]. This package is a collection of forms and includes forms for reporting on medicines delivered through the Joint Reporting Form (JRF), and medicines needed for future treatments through the Joint Request for Select Medicines (JRSM). These forms are submitted to WHO by national NTD Program Managers annually. Forms are reviewed and submitted to pharmaceutical partners who produce the medicines and ship the medicines to countries for distribution to endemic communities.
Functional requirements
Web annex B
Non-functional requirements
Web annex B
Actors - entities that interact with the system, derived from business requirements
Name | Administrative level | Description |
---|---|---|
Community member | Community | Target for MDA treatment |
Community Health Worker (CHW) | Community | Distribute MDA and report data associated with treatments delivered. The system could be implemented at this level. |
District Health Worker | District | District is the level of reporting treatments on annual reporting forms. This is the most likely level of implementing this system given the resources available at this level. |
NTD Program Manager | National | Collect data from all districts and report these data on annual reporting forms. National level could produce reports from data reported by either community or district level. |
WHO Country Office | National | Support national programs to complete annual reporting forms. Would have limited impact on this system. |
WHO Regional Office | Regional | First review of annual reporting forms. If this level was given access to data collected by this system, annual reporting forms could be pre populated through integration. |
WHO Central Office | Global | Final review of drug donation request. Would have limited use for this system. |
Pharmaceutical company | Global | Integration with this system would allow for early reporting of drugs used, wasted, and remaining. These data would improve forecasting for manufacturing. |
International shipment company | Global | Would have limited impact on this system. However, the shipping information is available for integration with national systems and that data combined with reporting medicine stock would provide a comprehensive review of received, used, requested medicines. |
Implementing partner | Global | Implementing partners would have no role in using this system. However, if they were given access to these data they too would have improved visibility on inventory and expiration. |
List of indicators across multiple tools
Reference: Data dictionary for supply reporting used in Kenya
Web annex A1: Data dictionary csv
Web annex A2: Data dictionary JSON
The first mile refers to the initial stages of the supply chain, from the pharmaceutical manufacturers or donors to the national or regional distribution centers. For NTD programs, first mile supply chain processes can be tracked through NTDeliver [link].
The last mile refers to the final stages of distribution, from national storage facilities to the community-level health workers or end-users. The activities and challenges associated with the last mile are the focus of this project and associated tools.
Key Activities:
Weak monitoring and reporting systems can lead to stockouts or over-distribution of medicines. Most often, the medicines used for MDA campaigns are not tracked using national logistics management information systems as they move from ports of entry, to central storage, and, ultimately, out to endemic communities. Similarly, reporting of the use of these medicines is a component of paper-based community registers and treatment summary forms. Limiting the access to these data until weeks after the MDA has concluded.
General data flow at national and global level
The tools provided here support the electronic submission of drug distribution during, or immediately following the MDA to a central database where these data can be accessed by all key actors and used for program management, reporting, and planning.
XLSForm [link] is a widely used open standard that ensures consistent implementation of advanced features like skip logic across various web and mobile data collection platforms. It enables users to author forms in a human-readable format with a familiar tool, Microsoft Excel, making collaboration and sharing more accessible. Tools that support XLSForms are commonly used in humanitarian aid, public health, and development projects due to their flexibility and interoperability.
Compatible web and mobile data collection platforms supporting XLSForm includes:
It is recommended that data are reported from whatever level is feasible given literacy, human resource constraints, and infrastructure constraints.
Community level
Ideally, data on MDA medicines distribution would be submitted from endemic communities on a daily basis. This would allow program managers and supervisors to monitor the progress of MDA and to make critical decisions when inventory deficits and surpluses need to be moved around.
Sub-district or district level
When community level reporting is not feasible, reporting would move to a higher administrative level, which would reduce the number of reporters, but also limit what actions could be taken with these data. Data submitted above the community level would primarily support the reporting of treatments delivered and remaining stock on annual reporting forms. These data could be made available to WHO and pharmaceutical partners, improving their ability to manufacture and ship medicines on time.
Dashboard example produced to report on drug used and remaining stock
Business rules:
Decisions from these data include:
There are multiple opportunities for system integration between the tools presented here and national Health Information Management Systems (HMIS), Logistic Information Management Systems (LMIS), NTD databases or data repositories, and, at the global level, WHO and NTDeliver.
Data are likely reported by district or reported by sub-district and aggregated to district for WHO annual reporting forms.
The key performance indicators (KPIs) for this tool are the following:
Reporting timelines:
Currently, inventory is reported once annually on the JAP annual reporting forms from countries to WHO. However, this cadence of reporting lacks interim visibility. Receiving all national drug requests at the same time places a burden on the manufacturing and shipment of donated medicines to endemic countries. The tools presented here provide an opportunity to report quantities of medical products at the time of distribution, providing greater visibility and the opportunity to integrate these data into manufacturing forecast models.